Atrial Fibrillation is a major medical concern around the world and affects >3% of the population*. Atrial fibrillation can be undetected due to the asymptomatic nature of the arrhythmia. According to the STROKESTOP study, around 5% of cases in the population that are at risk of developing atrial fibrillation can go undetected.
Regular opportunistic and targeted screening for patients can help detect the development of atrial fibrillation, this can lead to a decrease risk of AF associated Ischemic Stroke*
Book a demo with our team, to learn more about how Happitech’s clinically-validated PPG technology has assisted practitioners in screening and identifying heart rate and rhythm irregularities.